Antabio
Latest round
- Series B
Last raised
- Dec 2023
Total raised
- $43M
Investors
- 9
About Antabio
Antabio SAS, founded in 2009 in France, focuses on creating antibacterial therapies.Antabio is focused on developing innovative antibacterial therapies aimed at combating drug-resistant infections, particularly those identified as critical priorities by the World Health Organization (WHO). The company's main product pipeline includes MEM-ANT3310, a Pseudomonas elastase inhibitor (PEi), designed to specifically target pathogens resistant to standard antibiotics. These products are intended for use in healthcare settings, addressing the urgent need for effective treatments against nosocomial infections and antibiotic-resistant strains.Antabio's revenue model revolves around partnerships with healthcare institutions and pharmaceutical companies for the development and commercialization of its antibacterial products.30. The transaction structure typically involves direct sales agreements and strategic partnerships that facilitate the integration of their therapies into clinical practice. The company aims to expand its product offerings and develop new treatments to combat antimicrobial resistance. Plans for market expansion include targeting regions with high demand for effective antibacterial therapies, with particular focus on North America and Europe.
Who invested in Antabio
9 investors across 4 rounds
See all investors in Antabio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Antabio
Who invested in Antabio?
Antabio has 9 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Antabio raised?
Antabio has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Antabio last raise money?
Antabio's most recent round on record is a Series B, in Dec 2023.
What does Antabio do?
Antabio SAS, founded in 2009 in France, focuses on creating antibacterial therapies.
Where is Antabio headquartered?
Antabio is headquartered in France.
Which VCs invest in companies like Antabio?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Antabio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Antabio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.